Specialty pharmaceuticals is an important and fast growing part of the BioPharma industry. The following is generally true about specialty products:

 

 

1.   Small patient population combined with the need to educate patients and follow-up          with them underscores the importance of understanding the Patient Life Cycle. 

 

 

2.   High cost of therapy combined with the different sources of payments underscores       the importance of understanding the  Dollar Life Cycle.

 

 

3.   High value of the product and distribution via multiple channels underscores the             importance of understanding the Product Life Cycle.